$AIMD
Ainos, Inc.

2017 Q2 Form 10-Q Financial Statement

#000101476317000008 Filed on August 11, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $250.5K
YoY Change
Cost Of Revenue $58.80K
YoY Change
Gross Profit $191.7K
YoY Change
Gross Profit Margin 76.53%
Selling, General & Admin $176.9K $135.1K
YoY Change 30.94% 32.34%
% of Gross Profit 92.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $176.9K $135.1K
YoY Change 30.94% 32.34%
Operating Profit $14.77K -$135.1K
YoY Change -110.93% 32.34%
Interest Expense $1.742K $1.097K
YoY Change 58.8% 47.05%
% of Operating Profit 11.8%
Other Income/Expense, Net
YoY Change
Pretax Income $10.00K -$140.0K
YoY Change -107.14% 40.0%
Income Tax
% Of Pretax Income
Net Earnings $13.02K -$136.2K
YoY Change -109.56% 32.45%
Net Earnings / Revenue 5.2%
Basic Earnings Per Share
Diluted Earnings Per Share $0.01 -$0.10
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $70.00K $310.0K
YoY Change -77.42% 210.0%
Cash & Equivalents $69.38K $312.3K
Short-Term Investments
Other Short-Term Assets $90.00K $140.0K
YoY Change -35.71% 180.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $156.8K $453.8K
YoY Change -65.44% 202.52%
LONG-TERM ASSETS
Property, Plant & Equipment $35.61K $50.17K
YoY Change -29.03% 401.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $206.4K $135.0K
YoY Change 52.91% 50.02%
TOTAL ASSETS
Total Short-Term Assets $156.8K $453.8K
Total Long-Term Assets $206.4K $135.0K
Total Assets $363.3K $588.8K
YoY Change -38.31% 145.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $180.0K $100.0K
YoY Change 80.0% 0.0%
Accrued Expenses $10.00K $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $860.0K $790.0K
YoY Change 8.86% 192.59%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.235M $896.8K
YoY Change 37.68% 142.38%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.235M $896.8K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.235M $896.8K
YoY Change 37.68% 86.84%
SHAREHOLDERS EQUITY
Retained Earnings -$1.443M -$854.5K
YoY Change 68.82%
Common Stock $224.4K $213.9K
YoY Change 4.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$871.5K -$308.0K
YoY Change
Total Liabilities & Shareholders Equity $363.3K $588.8K
YoY Change -38.31% 145.33%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income $13.02K -$136.2K
YoY Change -109.56% 32.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$30.00K -$330.0K
YoY Change -90.91% 135.71%
INVESTING ACTIVITIES
Capital Expenditures $20.00K $60.00K
YoY Change -66.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$20.00K -$60.00K
YoY Change -66.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 70.00K 430.0K
YoY Change -83.72%
NET CHANGE
Cash From Operating Activities -30.00K -330.0K
Cash From Investing Activities -20.00K -60.00K
Cash From Financing Activities 70.00K 430.0K
Net Change In Cash 20.00K 40.00K
YoY Change -50.0% -128.57%
FREE CASH FLOW
Cash From Operating Activities -$30.00K -$330.0K
Capital Expenditures $20.00K $60.00K
Free Cash Flow -$50.00K -$390.0K
YoY Change -87.18% 178.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q1 amar Amount Of Private Placement
AmountOfPrivatePlacement
937500
amar Amount Of Private Placement
AmountOfPrivatePlacement
1875000
CY2017Q2 amar Common Stock Shares Outstanding And Reserved
CommonStockSharesOutstandingAndReserved
26747815
amar Conversion Of Accounts Payable Related Party To Convertible Note Payable Related Party
ConversionOfAccountsPayableRelatedPartyToConvertibleNotePayableRelatedParty
amar Conversion Of Accounts Payable Related Party To Convertible Note Payable Related Party
ConversionOfAccountsPayableRelatedPartyToConvertibleNotePayableRelatedParty
144426
amar Conversion Of Notes Payable Related Party To Convertible Note Payable Related Party
ConversionOfNotesPayableRelatedPartyToConvertibleNotePayableRelatedParty
amar Conversion Of Notes Payable Related Party To Convertible Note Payable Related Party
ConversionOfNotesPayableRelatedPartyToConvertibleNotePayableRelatedParty
384555
CY2017Q2 amar Customer Deposits Related Parties Current
CustomerDepositsRelatedPartiesCurrent
CY2016Q4 amar Customer Deposits Related Parties Current
CustomerDepositsRelatedPartiesCurrent
124833
CY2017Q2 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
791481
CY2016Q4 amar Notes Payable Convertible Related Parties Classified Current
NotesPayableConvertibleRelatedPartiesClassifiedCurrent
791481
amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
amar Proceeds From Convertible Notes Payable Related Party Debt
ProceedsFromConvertibleNotesPayableRelatedPartyDebt
262500
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
177224
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
165502
CY2017Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
346705
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
237540
CY2017Q2 us-gaap Assets
Assets
363256
CY2016Q4 us-gaap Assets
Assets
462676
CY2017Q2 us-gaap Assets Current
AssetsCurrent
156807
CY2016Q4 us-gaap Assets Current
AssetsCurrent
262399
us-gaap Interest Expense
InterestExpense
1459
us-gaap Interest Paid
InterestPaid
us-gaap Interest Paid
InterestPaid
CY2017Q2 us-gaap Inventory Net
InventoryNet
CY2016Q4 us-gaap Inventory Net
InventoryNet
14700
CY2017Q2 us-gaap Liabilities
Liabilities
1234728
CY2016Q4 us-gaap Liabilities
Liabilities
1272575
us-gaap Basis Of Accounting
BasisOfAccounting
<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif; WIDTH: 100%; TEXT-INDENT: 0px;" cellspacing="0" cellpadding="0" border="0"> <tr> <td style="WIDTH: 36pt; VERTICAL-ALIGN: top"><div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div><div style="display: inline; font-weight: bold;"></div></div></div></td> <td style="VERTICAL-ALIGN: top"> <div style=" MARGIN-BOTTOM: 0pt; TEXT-ALIGN: justify; MARGIN-TOP: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-weight: bold;">Basis of presentation.</div> The accompanying financial statements, which should be read in conjunction with the audited financial statements and footnotes included in the Company's Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>as filed with the Securities and Exchange Commission on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 17, 2017, </div>have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information. Accordingly, they do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2017 </div>are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the full year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017.</div></div></div></td> </tr> </table></div>
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69376
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
134125
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21138
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
312261
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-64749
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
291123
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22437176
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21916143
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22437176
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21916143
CY2017Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
4310639
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
224371
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
219161
CY2017Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
58801
CY2016Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
us-gaap Cost Of Goods Sold
CostOfGoodsSold
58801
us-gaap Cost Of Goods Sold
CostOfGoodsSold
5100
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
58801
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
us-gaap Cost Of Revenue
CostOfRevenue
58801
us-gaap Cost Of Revenue
CostOfRevenue
5100
CY2017Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
37835
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
37835
CY2017Q2 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
187500
CY2016Q4 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
187500
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
170843
CY2016Q4 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
156063
CY2017Q2 us-gaap Gross Profit
GrossProfit
191701
CY2016Q2 us-gaap Gross Profit
GrossProfit
us-gaap Gross Profit
GrossProfit
191701
us-gaap Gross Profit
GrossProfit
-700
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2017Q2 us-gaap Interest Expense
InterestExpense
1742
CY2016Q2 us-gaap Interest Expense
InterestExpense
1097
us-gaap Interest Expense
InterestExpense
5701
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
363256
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
462676
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1234728
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1272575
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
120625
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
684375
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-25786
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-68132
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-159588
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-325120
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
13024
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-136224
us-gaap Net Income Loss
NetIncomeLoss
-175948
us-gaap Net Income Loss
NetIncomeLoss
-257865
CY2017Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
70000
CY2016Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
CY2017Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
176935
CY2016Q2 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
135127
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
361948
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
255706
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14766
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-135127
us-gaap Operating Income Loss
OperatingIncomeLoss
-170247
us-gaap Operating Income Loss
OperatingIncomeLoss
-256406
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
25786
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
20446
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
47686
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49596
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
75739
CY2017Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
50625
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
421875
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
70000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35606
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
44214
CY2017Q2 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
-8523
CY2016Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
-3259
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1442548
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1266600
CY2017Q2 us-gaap Revenues
Revenues
250502
CY2016Q2 us-gaap Revenues
Revenues
us-gaap Revenues
Revenues
250502
us-gaap Revenues
Revenues
4400
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4400
CY2017Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
250502
CY2016Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
250502
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
176935
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
135127
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
361948
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
255706
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
-871472
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-809899
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22431427
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21069535
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22353918
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20607173

Files In Submission

Name View Source Status
0001014763-17-000008-index-headers.html Edgar Link pending
0001014763-17-000008-index.html Edgar Link pending
0001014763-17-000008.txt Edgar Link pending
0001014763-17-000008-xbrl.zip Edgar Link pending
amar-20170630.xml Edgar Link completed
amar-20170630.xsd Edgar Link pending
amar-20170630_cal.xml Edgar Link unprocessable
amar-20170630_def.xml Edgar Link unprocessable
amar-20170630_lab.xml Edgar Link unprocessable
amar-20170630_pre.xml Edgar Link unprocessable
exhibit31-1a_06302017.htm Edgar Link pending
exhibit31-1b_06302017.htm Edgar Link pending
exhibit32-1_06302017.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q_06302017.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending